HM
SUPN icon

Harvest Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Harvest Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$377K Buy
8,100
+1,000
+14% +$48K 0.15% 50
2026
Q1 		$367K Sell
7,100
-3,900
-35% -$199K 0.18% 46
2025
Q4 		$547K Buy
11,000
+1,000
+10% +$48.6K 0.18% 48
2025
Q3 		$478K Buy
+10,000
New +$403K 0.21% 48

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Harvest Management's SUPN Position: Q2 2026 in Review

Harvest Management increased its Supernus Pharmaceuticals (SUPN) stake by 14% in Q2 2026, buying an estimated $48K and bringing the position to 8,100 shares worth $377K. The position accounts for 0.15% of the portfolio, ranked #50.

Harvest Management first reported a position in SUPN in Q3 2025 and has held it in 4 quarters since. The position peaked at $547K in Q4 2025. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Harvest Management held 8,100 shares of Supernus Pharmaceuticals worth $377K as of Q2 2026.
  • Harvest Management bought 1,000 Supernus Pharmaceuticals shares in Q2 2026, an estimated $48K.
  • Supernus Pharmaceuticals made up 0.15% of Harvest Management's portfolio in Q2 2026, its #50 holding.
  • Harvest Management first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Harvest Management's Supernus Pharmaceuticals position peaked at $547K in Q4 2025.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Harvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.